The cardiovascular biomarker qualities of copeptin have been extensively studied in various clinical cases, particularly in the diagnosis and prognosis of myocardial infarction and CAD, as well as in the diagnosis and prognosis of heart failure. This evidence concerns the gene AVP and heart failure.